In a new study of more than 40,000 patients, researchers at Intermountain Health in Salt Lake City have found that patients who have no evidence of calcium in ...

Recent developments in reimbursement and insurer coverage for plaque analysis in the US are a step towards the evaluative ...

Cardiologists have spent decades trying to stabilize the fatty plaques that clog arteries, but a new wave of immunotherapy is ...

Scientists have designed an immunotherapy that reduces plaque in the arteries of mice, presenting a possible new treatment strategy against heart disease. The antibody-based therapy could complement ...

Please provide your email address to receive an email when new articles are posted on . Alirocumab plus high-intensity statin therapy improved coronary plaque burden in patients with familial ...

Coverage unlocks reimbursable AI plaque quantification, advancing coronary risk assessment in everyday cardiology practice ...

Holy Cross Medical Center is expanding heart care for northern New Mexico residents with the introduction of HeartFlow Plaque ...

BOSTON--(BUSINESS WIRE)--Elucid today announced that, effective January 1, 2026, its Plaque-IQ™ coronary plaque analysis has received a new Category I Current Procedural Terminology (CPT®) designation ...

Engineered BiTE molecule draws T cells to eliminate FAP+ modulated smooth muscle cells, reducing plaque burden across mouse atherosclerosis models.

Which patients with a history of myocardial infarction (MI) are at risk of having another? The tools to predict risk for recurrent cardiac events in patients with established coronary artery disease ...

More than half of people living with HIV and suppressed viral loads nonetheless had imaging-confirmed coronary artery disease — and despite longtime use of HIV drugs that have been associated with ...